- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-09-0003908

Dnsco Pharma Private Limited
About Dnsco Pharma Private Limited
Data last updated:
Dnsco Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 16 July 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1991PTC044992. Its GSTIN is 07AAACD0234E1ZD (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kanav Nangia and Neelu Nangia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H – 9 Lajpat Nagar II, New Delhi, Delhi, India – 110024.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.27 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹1.1 Cr (net margin 25.8%) and EBITDA of ₹1.86 Cr (EBITDA margin 43.5%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 30% over five years.
Dnsco Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-09-0003908). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Dnsco Pharma
Contact details
Dnsco Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH – 9 Lajpat Nagar II, New Delhi, Delhi, India – 110024
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Dnsco Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dnsco Pharma is administrative and support service activities. In detail, this covers office administrative, office support and other business support activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Administrative and support service activities | 82 | Office administrative, office support and other business support activities |
To see the full business activity and turnover split of Dnsco Pharma Private Limited, buy the company report.
Financials of Dnsco Pharma Private Limited
FY 2025 filings availableDnsco Pharma Private Limited reported revenue of ₹4.27 Cr (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 31% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.86 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.1 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 43.5% | ||||
| Net Profit Margin | 25.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dnsco Pharma Private Limited, buy the company report.
Board of directors of Dnsco Pharma Private Limited
Dnsco Pharma has 14 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kanav Nangia Also directs: Nine Associates LLP | Director | 01 May 2013 | 13 Years 6 Months | Current |
| Neelu Nangia Also directs: Essen Medicare LLP | Director | 07 Apr 1993 | 33 Years 7 Months | Current |
| Sanjeev Nangia | Director | 01 Oct 1999 | 27 Years 1 Months | Current |
| Sakshi Gupta | Director | 01 Aug 2023 | 3 Years 3 Months | Current |
| Naiyaa Arora Also directs: Essen Medicare LLP | Director | 01 Jun 2021 | 5 Years 5 Months | Current |
| Gunpreet Kaur Sodhi | Director | 01 Jun 2022 | 4 Years 5 Months | Current |
Peer comparison
Dnsco Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (office administrative, office support and other business support activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saisamrthk Enterprises India Private Limited | ₹4.32 Cr (FY 2025) | 5.0% | Ahmednagar, Maharashtra, India | |||
| Indepth Brand Solution Private Limited | ₹4.32 Cr (FY 2025) | 49.0% | Delhi, India | |||
| Infruit Events Private Limited | ₹4.3 Cr (FY 2024) | 58.0% | Gurgaon, Haryana, India | |||
| Dornbracht India Private Limited | ₹4.29 Cr (FY 2025) | 9.0% | Mumbai, Maharashtra, India | |||
| Newline Inno-Source Private Limited | ₹4.28 Cr (FY 2024) | 1232.0% | Mumbai, Maharashtra, India | |||
| Dnsco Pharma Private Limitedthis company | ₹4.27 Cr (FY 2025) | ₹1.1 Cr | 25.8% | 31.0% | New Delhi, Delhi, India | |
| Regus Orchid Business Centre Private Limited | ₹4.26 Cr (FY 2025) | 98.0% | Mumbai, Maharashtra, India | |||
| Foreign Exchange Dealers Association of India | ₹4.26 Cr (FY 2025) | -6.0% | Mumbai, Maharashtra, India | |||
| Regus Business Centre (Mumbai) Private Limited | ₹4.26 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| ZCJ Industrial Private Limited | ₹4.23 Cr (FY 2025) | 2.0% | New Delhi, Delhi, India | |||
| Frontline Bizsol India Private Limited | ₹4.23 Cr (FY 2025) | -5.0% | Pune, Maharashtra, India |
To see the full peer comparison of Dnsco Pharma Private Limited, buy the company report.
Shareholding
The shareholding of Dnsco Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Dnsco Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dnsco Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dnsco Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dnsco Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACD0234E1ZD | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dnsco Pharma Private Limited, buy the company report.
Recent activity
Dnsco Pharma Private Limited has 22 board changes on record since 1993: 14 appointments and 8 cessations. The latest: Sabina Nangia was appointed as Additional Director on 18 Apr 2025.
13 earlier events are in the company report.
Frequently asked questions
Dnsco Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 16 July 1991 (35+ years old) and is registered under CIN U74899DL1991PTC044992.
Dnsco Pharma has 14 current directors:
- Kanav Nangia - Director
- Neelu Nangia - Director
- Sanjeev Nangia - Director
- Sakshi Gupta - Director
- Naiyaa Arora - Director
- Gunpreet Kaur Sodhi - Director
- Hina Nangia - Director
- Karan Nangia - Additional Director
- Nikita Nangia - Director
- Sandeep Nangia - Director
- Rohan Nangia - Additional Director
- Sanjay Nangia - Additional Director
- Sabina Nangia - Additional Director
- Anjum Nangia - Additional Director
The latest financial statements of Dnsco Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dnsco Pharma is 07AAACD0234E1ZD, registered in Delhi.
The CIN (Corporate Identification Number) of Dnsco Pharma is U74899DL1991PTC044992. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dnsco Pharma was incorporated on 16 July 1991, making it 35+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Dnsco Pharma by revenue are Saisamrthk Enterprises India Private Limited, Indepth Brand Solution Private Limited, Infruit Events Private Limited, Dornbracht India Private Limited, Newline Inno-Source Private Limited and 5 more, all in the same principal business activity (office administrative, office support and other business support activities).
Sabina Nangia was appointed as Additional Director on 18 Apr 2025. Sanjay Nangia was appointed as Additional Director on 18 Apr 2025. Anjum Nangia was appointed as Additional Director on 01 Apr 2025. Dnsco Pharma has 22 board changes on record in total.
Yes, Dnsco Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-09-0003908).
The registered office of Dnsco Pharma is at H – 9 Lajpat Nagar II, New Delhi, Delhi, India – 110024.
Dnsco Pharma operates in the trading industry, in the wholesale segment.

